ANSM — authorised 14 February 2022
- Marketing authorisation holder: GLOBAL BLOOD THERAPEUTICS NETHERLANDS B. V.
- Status: approved
🇫🇷 Oxbryta in France
ANSM authorised Oxbryta on 14 February 2022
Marketing authorisation
Oxbryta in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in France
Frequently asked questions
Is Oxbryta approved in France?
Yes. ANSM authorised it on 14 February 2022.
Who is the marketing authorisation holder for Oxbryta in France?
GLOBAL BLOOD THERAPEUTICS NETHERLANDS B. V. holds the French marketing authorisation.